Sectoral Asset Management’s Revolution Medicines RVMD Stock Holding History

Sectoral Asset Management’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$202K	Buy	+1,830	New	+$185K	0.17%	76
2025 Q3	–	Sell	-6,240	Closed	-$230K	–	91
2025 Q2	$230K	Hold	6,240	–	–	0.15%	83
2025 Q1	$221K	Buy	6,240 +1,340	+27%	+$54.4K	0.17%	69
2024 Q4	$214K	Sell	4,900 -1,530	-24%	-$77.2K	0.14%	74
2024 Q3	$292K	Sell	6,430 -170	-3%	-$7.4K	0.17%	78
2024 Q2	$256K	Sell	6,600 -6,310	-49%	-$236K	0.1%	85
2024 Q1	$416K	Sell	12,910 -800	-6%	-$23.7K	0.16%	77
2023 Q4	$393K	Sell	13,710 -128,940	-90%	-$3.1M	0.17%	85
2023 Q3	$3.95M	Buy	+142,650	New	+$4.23M	0.77%	57
2021 Q1	–	Sell	-389,006	Closed	-$15.4M	–	128
2020 Q4	$15.4M	Sell	389,006 -244,084	-39%	-$9.65M	1.09%	35
2020 Q3	$22M	Buy	+633,090	New	+$17.5M	1.89%	18

Other funds holding RVMD

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sectoral Asset Management's RVMD Position: Q1 2026 in Review

Sectoral Asset Management opened a new position in Revolution Medicines (RVMD) in Q1 2026: 1,830 shares worth $202K. The stake represents 0.17% of the portfolio and ranks #76 among its holdings. This is a return to the name: Sectoral Asset Management previously reported a position in RVMD as recently as Q2 2025.

Sectoral Asset Management first reported a position in RVMD in Q3 2020 and has held it in 11 quarters since. The position peaked at $22M in Q3 2020. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

Sectoral Asset Management held 1,830 shares of Revolution Medicines worth $202K as of Q1 2026.
Revolution Medicines was a new Sectoral Asset Management position in Q1 2026.
Revolution Medicines made up 0.17% of Sectoral Asset Management's portfolio in Q1 2026, its #76 holding.
Sectoral Asset Management first reported a position in Revolution Medicines in Q3 2020 and has held it in 11 quarters since.
Sectoral Asset Management's Revolution Medicines position peaked at $22M in Q3 2020.
512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Sectoral Asset Management's 13F filing for Q1 2026, filed 15 May 2026.